AstraZeneca says U.S. trial data shows its Covid-19 vaccine is 79 percent effective

Source: NBC News

By Patrick Smith and Reuters

LONDON — A vaccine developed by AstraZeneca and Oxford University is highly effective at stopping Covid-19 and completely prevents severe illness and hospitalization across all age groups, the company announced on Monday.

AstraZeneca said it will now apply to the Food and Drug Administration for emergency use authorization and release its data for analysis by the scientific community in peer-reviewed literature.

The Phase 3 trial, conducted in the U.S., Chile and Peru with 32,000 volunteers, showed the vaccine was 79 percent effective against the disease and 100 percent effective in stopping severe and fatal cases, the company said in a news release.

Read further

Categories: Vaccine

1 reply

  1. AstraZeneca Plc may have released outdated information about its Covid-19 vaccine trial, giving an “incomplete” view of the efficacy of the shot, said the leading U.S. agency on infectious diseases.

    The Data and Safety Monitoring Board, charged with ensuring the safety and accuracy of AstraZeneca’s vaccine trial, has expressed concerns to the National Institute for Allergy and Infectious Diseases that the information released about the testing results included outdated information.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.